医学
不宁腿综合征
神经调节
物理疗法
神经系统疾病
慢性疼痛
麻醉
物理医学与康复
单中心
神经病理性疼痛
评定量表
回顾性队列研究
脊髓损伤
中枢神经系统疾病
相伴的
经皮神经电刺激
脊髓刺激
疾病严重程度
睡眠障碍
脑深部刺激
病理生理学
脊髓
康复
生物反馈
磁刺激
脑干听觉诱发电位
复杂局部疼痛综合征
多导睡眠图
神经学
电话采访
肌电图
病历
脊髓刺激器
作者
Elijah Wang,Garrett W. Thrash,Riyaz Razi,Yifei Sun,Keith McGregor,Prasad R. Shirvalkar,Harrison C. Walker,Christopher J. Earley,Marshall T. Holland
摘要
INTRODUCTION: Restless legs syndrome (RLS) is a lifelong disorder characterized by recurrent, uncomfortable sensations and irresistible urges to move the legs that peak in the evening. Spinal cord stimulation (SCS) is a longstanding neuromodulation treatment for chronic neuropathic pain with emerging evidence of potential effectiveness toward RLS through a potential shared pathophysiology of central sensitization. METHODS: A retrospective review of our institution's electronic health record system was performed to identify patients who received SCS for chronic pain with a concomitant RLS diagnosis. Patients who had a diagnosis of RLS in their chart were secondarily confirmed to have RLS using the Cambridge-Hopkins RLS Questionnaire via telephone. The International Restless Leg Syndrome (IRLSS) Study Group Rating Scale and multiple Patient-Recorded Outcomes Measurements System (NIH PROMIS) of sleep data were obtained via telephone with patients recalling their symptoms pre- and post-SCS implantation. RESULTS: A group of 11 patients with an existing SCS system implanted for chronic pain and comorbid RLS confirmed on the Cambridge-Hopkins questionnaire were identified. The IRLS summed score showed a statistically significant (p = 0.0343) improvement with a large effect size (r = 0.64) indicating that overall symptom severity measured by the IRLS scale decreased significantly with SCS. There was also a significant (p = 0.0223) reduction with a large effect size (r = 0.69) in the summed NIH PROMIS sleep-related impairment scores, suggesting that SCS had a substantial positive impact on sleep-related impairments. Contrary to this, insignificant (p = 0.778) changes were observed in the summed NIH PROMIS sleep disturbance scores with a small effect size (r = 0.09). CONCLUSION: SCS has been shown to be an effective, novel treatment for chronic pain but also has positive effects on medication refractory RLS. While this small, retrospective study is limited by recall bias, it provides further evidence of SCS serendipitously improving RLS symptoms. Future prospective research evaluating the effects of SCS on RLS symptoms, pathophysiology, and sleep is needed to further evaluate this phenomenon.
科研通智能强力驱动
Strongly Powered by AbleSci AI